Clinical Services > Respiratory

COPD management: trial to address deficiencies in primary care

13 May, 2022

A Cochrane Review has highlighted an urgent need to identify the best type of interventions to improve guideline-recommended management of COPD as well as patient-related outcomes in the primary care setting.

BOC O2matic PRO automated closed-loop oxygen therapy

23 August, 2021

The O2matic PRO from BOC is designed to quickly stabilise arterial oxygen saturation in patients suffering from conditions that can lead to respiratory distress.

Sydney-developed COVID-19 nasal spray seeks trial participants

22 July, 2021

ENA Respiratory is seeking 100 healthy Sydneysiders to participate in a phase I study of its anti-COVID-19 nasal spray.

Oxair addresses global oxygen supply shortage

01 April, 2021

In response to global shortages, Oxair is spreading the word about its off-the-shelf solution — Oxygen Pressure Swing Adsorption (PSA) systems.

National Asthma Council Australia urges asthmatics to get vaccinated

29 March, 2021

Updates to the Australian Asthma Handbook will help health professionals advise patients with asthma during the COVID-19 vaccine rollout.

Summing up health costs of the last bushfire season

01 October, 2020

Australian researchers have found that the 2019–2020 bushfire season racked up smoke-related health costs of around $1.95 billion.

Study reveals long COVID-19 recovery

12 August, 2020

University of Leeds researchers have identified a pattern of long-term symptoms experienced by people hospitalised with COVID-19.

In Conversation with Dr Harrison Steel

16 July, 2020

Dr Harrison Steel has been directly involved in two significant projects that have impacted the COVID-19 health crisis.

Preview released for updated Australian Asthma Handbook

15 June, 2020

The National Asthma Council Australia has released a preview of the updated Australian Asthma Handbook V2.1.

National Taskforce recommends remdesivir for COVID-19

05 June, 2020

The antiviral drug is the first medication to be recommended as a considered treatment for hospitalised patients with the condition.

Self-administration option available for severe asthma subtype

01 June, 2020

A new self-administered treatment for severe eosinophilic asthma will be reimbursed by the Pharmaceutical Benefits Scheme from 1 June 2020.

What factors increase risk of severe COVID-19 or death?

26 May, 2020

A UK study has revealed that age, male sex, obesity and underlying illness emerge as risk factors for severe COVID-19 or death.

Mucus biology leap is a path to airway clearing

21 May, 2020

New insights into the molecular mechanisms driving mucus viscosity could help improve airway-clearing treatment options for patients with respiratory conditions.

COVID-19 advice for asthmatics on World Asthma Day

05 May, 2020

Doctors are giving advice to the 2.7 million Australians with asthma about how the novel coronavirus affects them.

Vaping: risky business or sensible quit strategy?

08 April, 2020 by Jane Allman

E-cigarettes containing nicotine are illegal in Australia. Some health experts believe they shouldn't be...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd